Alerts will be sent to your verified email
Verify EmailADVIKLA
MPS Pharmaa
|
Fabino Enterprises
|
Zyden Gentec
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-41.86 % | 0.76 % | -24.76 % |
5yr average Equity Multiplier
|
3.24 | 2.01 | 2.0 |
5yr Average Asset Turnover Ratio
|
0.0 | 0.98 | 0.21 |
5yr Avg Net Profit Margin
|
-5434.45 % | 0.54 % | -137.59 % |
Price to Book
|
4.63 | 0.0 | n/a |
P/E
|
0.0 | 85.2 | n/a |
5yr Avg Cash Conversion Cycle
|
0.0 | 59.85 Days | 785.76 Days |
Inventory Days
|
1258.79 Days | 81.8 Days | 134.34 Days |
Days Receivable
|
0.0 | 131.05 Days | 803.05 Days |
Days Payable
|
414.72 Days | 60.4 Days | 421.99 Days |
5yr Average Interest Coverage Ratio
|
-816.29 | 5.69 | -2.08 |
5yr Avg ROCE
|
-41.48 % | 1.29 % | -6.92 % |
5yr Avg Operating Profit Margin
|
-3500.38 % | 1.24 % | -95.87 % |
5 yr average Debt to Equity
|
1.97 | 0.14 | 0.68 |
5yr CAGR Net Profit
|
-6.64 % | -4.36 % | -1.66 % |
5yr Average Return on Assets
|
-13.25 % | 0.49 % | -15.88 % |
Shareholdings
|
|||
Promoter Holding
|
35.89 % | 56.82 % | 0.0 |
Share Pledged by Promoters
|
16.04 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -17.28 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
MPS Pharmaa
|
Fabino Enterprises
|
Zyden Gentec
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|